K. Igeta

发表

Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80.

N. Inagaki, H. Nagai, N. Shiraishi, 2002, European journal of pharmacology.

Characterization of gastrointestinal drug absorption in cynomolgus monkeys.

S. Yamashita, N. Suzuki, M. Hayashi, 2008, Molecular pharmaceutics.

Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis model.

J. Yasuda, K. Igeta, T. Morikawa, 2002, Bioorganic & medicinal chemistry.

Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.

Hiroyuki Tanaka, N. Inagaki, H. Nagai, 2010, European journal of pharmacology.

Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.

N. Inagaki, H. Nagai, Takao Chikumoto, 2006, European journal of pharmacology.

Evaluation and Characterization of Mouse Scratching Behavior by a New Apparatus, MicroAct

H. Nagai, M. Nagao, K. Igeta, 2003, Skin Pharmacology and Physiology.

Evaluation of anti-scratch properties of oxatomide and epinastine in mice.

N. Inagaki, H. Nagai, H. Kawasaki, 2000, European journal of pharmacology.

Human Pharmacokinetic Prediction of UDP-Glucuronosyltransferase Substrates with an Animal Scale-Up Approach

Osamu Okazaki, Atsushi Kurihara, N. Suzuki, 2011, Drug Metabolism and Disposition.

Scratching Behavior in Various Strains of Mice

N. Inagaki, H. Nagai, H. Kawasaki, 2001, Skin Pharmacology and Physiology.

The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans.

S. Yamashita, N. Suzuki, Shinji Yamashita, 2009, Journal of pharmaceutical sciences.

Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.

S. Yamashita, N. Suzuki, Masayuki Takahashi, 2010, Biological & pharmaceutical bulletin.